Oncothermia Journal
Volume 6



Download the full journal


Dani A, Varkonyi A, Magyar T, Kalden M, Szasz A (2012) Clinical study for advanced pancreas cancer treated by oncothermia. Oncothermia Journal 6:11-25

“Abstract Pancreas cancer (PCA) is an aggressive, common malignant tumor. We present two retrospective clinical studies of PCA done in two medical centers (HTT-MED Day-clinic and Peterfy Hospital). Both of the centers made the treatments by oncothermia in combination with the conventional tumor-therapies. We present the data from both centers and make a metaanalysis of the data as well. Results show a remarkable survival benefit for the patients compared to the historical data. The comparison of the studies shows a good correspondence in the data, which strengthens the reliability of the studies, and points out the feasibility of the oncothermia application on PCA….”


Douwes FR (2012) Is an Integrative Cancer Therapy Concept (ICTC) the answer to improve the present situation in cancer care? Oncothermia Journal 6:27-32

“Introduction The demand for integrative oncology is on the upswing as both patients and doctors grow impatient with the failed war on cancer, internationally. More and more physicians move away from a one-size-fits-all kind of treatment to an integrated, patient-centered approach as we practice it at St. George Hospital, since more than twenty years. Cancer is a multibillion Euro market that is growing fast and companies make a lot of money on something that doesn't work that well. Metastases are the major cause of death in cancer. Yet from 1972 to 2004, only 0.5% of the official Multi-Center studies focused primarily on metastasis….”


Douwes FR (2012) Cancer Treatment Approach at St. George Hospital. Oncothermia Journal 6:34-45

“We focus upon treating patients individually, and addressing the particular characteristics of their cancers, as well as their ability to detoxify. This includes stimulating the immune system to help it recognize cancer. We use three non toxic treatment modalities to destruct cancer within the body, so that it can be recognized by the immune system. This is in the first line hyperthermia (heat treatment), electro cancer therapy (ECT) and photodynamic therapy (PDT). With these three treatment modalities we not only have the possibility to reduce the cancer mass gently within the body, but we also change the immunogenicity of the cancer by inducing heat shock proteins, for instance HSP 70, so that the tumor can be recognized and then destructed by the immune system….”


Douwes FR (2012) Hyperthermia: a treatment possibility for prostate cancer. Oncothermia Journal 6:47-53

“Introduction Early detection of prostate cancer (PC), as, in all malignancies, is very important, so that withappropriate therapy the chances of a cure increase. The prostate cancer screening guidelines suggest, next to surgical removal of the prostate (prostatectomy) and the various forms of radiation, to monitor the patient through “Active Surveillance”. This controlled and regularly executed observation is especially used in patients with a slow-growing tumor (so-called insignificant prostate cancer). This type of prostate cancer is characterized by minor tumor volume and less aggressive growth. The latest studies on this subject show that the results of the “Active Surveillance” are as good as after invasive procedures, such as surgical removal of the prostate or radiation….”


Breitkreutz F (2012) Regionale Elektrohyperthermie: Ordnungsgemäße Abrechnung und Erstattungsfähigkeit. Oncothermia Journal 6:55-66

„Hyperthermische Verfahren werden in der Zivilgerichtsbarkeit mittlerweile bei den verschiedensten Tumoridentitäten als medizinisch notwendige Heilbehandlung eingestuft, deren Kosten von den privaten Krankenversicherungen zu erstatten sind. Auch die gesetzlichen Krankenversicherungen werden - trotz expliziter Bewertung der Hyperthermie als in der vertragsärztlichen Versorgung nicht anerkannter Behandlungsmethode - in lebensbedrohlichen Situationen mehr und mehr dazu verurteilt, hyperthermische Behandlungen als Sachleistung zu gewähren….”


 

Oncotherm